Literature DB >> 16455450

Nonalcoholic Fatty gallbladder disease: the influence of diet in lean and obese mice.

Matthew I Goldblatt1, Deborah A Swartz-Basile, Hayder H Al-Azzawi, Khoi Q Tran, Attila Nakeeb, Henry A Pitt.   

Abstract

The obesity epidemic has contributed to an increased prevalence of gallstones and a higher percentage of chronic acalculous cholecystitis. Obesity is associated with Type II diabetes and hyperlipidemia in murine models. In addition, we have previously demonstrated that serum glucose, insulin, cholesterol, and triglycerides correlated with gallbladder contractility in murine models. However, the relative role of insulin resistance and gallbladder fat infiltration in this phenomenon remain unclear. Therefore, we tested the hypothesis that gallbladder wall lipids are related to obesity and diet and are inversely correlated with gallbladder contractility. One hundred lean control (C7BL/6J) and 36 obese leptin-deficient (Lep(ob)) 8-week-old female mice were fed either a chow diet or a 1.0% cholesterol, 15% butterfat (high-lipid) diet for four weeks. Pooled gallbladders were then analyzed for free fatty acids (FFA), phospholipids (PL), total cholesterol (TC), and triglycerides (TG). Cholesterol/phospholipid ratios were then calculated. The Lep(ob) mice fed a chow diet had significantly higher (P < 0.01) gallbladder lipids than the three other groups. The lean mice that were fed a high-lipid diet had increased (P < 0.05) gallbladder TC compared to the lean mice on a chow diet. In addition, the cholesterol/phospholipid ratio was significantly increased (P < 0.01) in the lean mice fed a high-lipid diet compared to the other three groups. Finally, the high-lipid diet decreased gallbladder FFA (P < 0.01), PL (P = 0.08), and TC (P < 0.05) in Lep(ob) mice. These data suggest that (1) obese mice have increased gallbladder lipids; (2) a high-cholesterol, high-fat diet increases gallbladder lipids and the cholesterol/phospholipid ratio in lean mice; but (3) decreases gallbladder fatty acids, phospholipids, and cholesterol in obese mice. Prior studies have documented similarly decreased gallbladder response to neurotransmitters in obese mice on a chow diet, as well as lean and obese mice on a high-lipid diet. Therefore, we conclude that leptin-deficient obesity and/or a high-fat diet causes nonalcoholic fatty gallbladder disease, which is manifested by diminished gallbladder contractility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455450     DOI: 10.1016/j.gassur.2005.07.009

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Enhanced gallbladder absorption during gallstone formation: the roles of cholesterol saturated bile and gallbladder stasis.

Authors:  J J Roslyn; J Doty; H A Pitt; R L Conter; L Den Besten
Journal:  Am J Med Sci       Date:  1986-08       Impact factor: 2.378

2.  Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells.

Authors:  M M Gleason; M S Medow; T N Tulenko
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

Review 3.  Leptin--much more than a satiety signal.

Authors:  R B Harris
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

4.  Decreased gallbladder response in leptin-deficient obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

5.  Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.

Authors:  Q Chen; J Amaral; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

6.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

7.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

8.  Gallbladder myocytes are short and cholecystokinin-resistant in obese diabetic mice.

Authors:  Shannon J Graewin; Keun-Ho Lee; James M Kiely; Carol L Svatek; Attila Nakeeb; Henry A Pitt
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity.

Authors:  Khoi Q Tran; Matthew I Goldblatt; Deborah A Swartz-Basile; Carol Svatek; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.267

View more
  9 in total

1.  Resistin-like molecule alpha reduces gallbladder optimal tension.

Authors:  Hayder H Al-Azzawi; Abhishek Mathur; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

2.  Insulin resistance causes human gallbladder dysmotility.

Authors:  Attila Nakeeb; Anthony G Comuzzie; Hayder Al-Azzawi; Gabriele E Sonnenberg; Ahmed H Kissebah; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

3.  Steatocholecystitis: the influence of obesity and dietary carbohydrates.

Authors:  Abhishek Mathur; Hayder H Al-Azzawi; Debao Lu; Kyle W Yancey; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Surg Res       Date:  2007-10-22       Impact factor: 2.192

4.  Nonalcoholic fatty pancreas disease.

Authors:  Abhishek Mathur; Megan Marine; Debao Lu; Deborah A Swartz-Basile; Romil Saxena; Nicholas J Zyromski; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

5.  Cholecystosteatosis: an explanation for increased cholecystectomy rates.

Authors:  Hayder H Al-Azzawi; Attila Nakeeb; Romil Saxena; Mary A Maluccio; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 6.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

7.  Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology.

Authors:  Nicholas J Zyromski; Abhishek Mathur; G A Nagana Gowda; Carl Murphy; Deborah A Swartz-Basile; Terence E Wade; Henry A Pitt; Daniel Raftery
Journal:  Pancreatology       Date:  2009-05-19       Impact factor: 3.996

8.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

9.  Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Yasar Colak; Gulcin Bozbey; Tolga Erim; Ozge Telci Caklili; Celal Ulasoglu; Ebubekir Senates; Hasan Huseyin Mutlu; Banu Mesci; Mehmet Sait Doğan; Guralp Tasan; Feruze Yilmaz Enc; Ilyas Tuncer
Journal:  J Neurogastroenterol Motil       Date:  2016-07-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.